ERNAW
Financials
- Market Capitalization 7.7794 M
- Employee 5
- Founded 2018
- CEO N/A
- Website www.ernexatx.com
- Headquarter Delaware, United States
- FIGI BBG000CX5677
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5351 |  GRFS Grifols, S.A. - American Depositary Shares | 7.22 USD | +2.85% | -1.23% | -4.87% | -28.16% | 0 USD | ||
| 7339 |  SCLXW Scilex Holding Company - Warrant | 0.2000 USD | -3.61% | +0.05% | -3.61% | +22.85% | 78.46 M USD | ||
| 7453 |  MDCXW Medicus Pharma Ltd. - Warrant | 0.4800 USD | -5.88% | -38.77% | +33.30% | -49.47% | 19.83 M USD | ||
| 7491 |  LIMNW Liminatus Pharma, Inc. - Warrants | 0.0500 USD | 0.00% | -0.20% | -18.03% | -64.54% | 4.94 M USD |
Frequently asked questions about Ernexa Therapeutics Inc. - Warrants
What is the Ernexa Therapeutics Inc. - Warrants stock price today?
The current price of Ernexa Therapeutics Inc. - Warrants (ERNAW) is 0.0851. Over the past 24 hours, the stock has changed by 0.00%. Follow the ERNAW chart for real-time price dynamics.
What is the stock ticker of Ernexa Therapeutics Inc. - Warrants?
Ernexa Therapeutics Inc. - Warrants trades under the ticker ERNAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ernexa Therapeutics Inc. - Warrants stock going up?
ERNAW has changed by -22.64% over the last week, -22.71% over the last month, and -14.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ernexa Therapeutics Inc. - Warrants net income for the last quarter?
Ernexa Therapeutics Inc. - Warrants reported net income of -5.51 M for the last quarter. The previous quarter showed -1.5 M, which means net income changed by -266.33%.
How many employees does Ernexa Therapeutics Inc. - Warrants have?
As of the latest available data, Ernexa Therapeutics Inc. - Warrants has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ernexa Therapeutics Inc. - Warrants EBITDA?
Ernexa Therapeutics Inc. - Warrants EBITDA is -5.57 M, and its EBITDA margin is -39.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ernexa Therapeutics Inc. - Warrants stock?
You can buy Ernexa Therapeutics Inc. - Warrants (ERNAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ernexa Therapeutics Inc. - Warrants stock?
Investing in Ernexa Therapeutics Inc. - Warrants requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ERNAW chart and related analysis on metatrader.com as part of your research.